Thorsten Stiewe
Thorsten Stiewe
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Role of the p53-homologue p73 in E2F1-induced apoptosis
T Stiewe, BM Pützer
Nature genetics 26 (4), 464-469, 2000
The p53 family in differentiation and tumorigenesis
T Stiewe
Nature Reviews Cancer 7 (3), 165-167, 2007
Transactivation-deficient ΔTA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis
T Stiewe, CC Theseling, BM Pützer
Journal of Biological Chemistry 277 (16), 14177-14185, 2002
Transactivation-deficient ΔTA-p73 acts as an oncogene
T Stiewe, S Zimmermann, A Frilling, H Esche, BM Pützer
Cancer research 62 (13), 3598-3602, 2002
Gene expression changes in response to E2F1 activation
J Stanelle, T Stiewe, CC Theseling, M Peter, BM Pützer
Nucleic acids research 30 (8), 1859-1867, 2002
Role of p73 in malignancy: tumor suppressor or oncogene?
T Stiewe, BM Pützer
Cell Death & Differentiation 9 (3), 237-245, 2002
A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism
A Pribluda, E Elyada, Z Wiener, H Hamza, RE Goldstein, M Biton, ...
Cancer cell 24 (2), 242-256, 2013
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M Michaelis, F Rothweiler, S Barth, J Cinatl, M Van Rikxoort, ...
Cell death & disease 2 (12), e243-e243, 2011
The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes
M Luu, S Pautz, V Kohl, R Singh, R Romero, S Lucas, J Hofmann, ...
Nature communications 10 (1), 1-12, 2019
p53 family members in myogenic differentiation and rhabdomyosarcoma development
H Cam, H Griesmann, M Beitzinger, L Hofmann, R Beinoraviciute-Kellner, ...
Cancer cell 10 (4), 281-293, 2006
Immune and inflammatory cell composition of human lung cancer stroma
GA Banat, A Tretyn, SS Pullamsetti, J Wilhelm, A Weigert, C Olesch, ...
PLOS one 10 (9), e0139073, 2015
Quantitative TP73 Transcript Analysis in Hepatocellular Carcinomas
T Stiewe, S Tuve, M Peter, A Tannapfel, AH Elmaagacli, BM Pützer
Clinical cancer research 10 (2), 626-633, 2004
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
E Kadosh, I Snir-Alkalay, A Venkatachalam, S May, A Lasry, E Elyada, ...
Nature 586 (7827), 133-138, 2020
DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis
K Schlereth, R Beinoraviciute-Kellner, MK Zeitlinger, AC Bretz, M Sauer, ...
Molecular cell 38 (3), 356-368, 2010
p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo
O Timofeev, K Schlereth, M Wanzel, A Braun, B Nieswandt, ...
Cell reports 3 (5), 1512-1525, 2013
p73 in apoptosis
T Stiewe, BM Pützer
Apoptosis 6 (6), 447-452, 2001
Antithetical NFAT c1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
SK Singh, NM Chen, E Hessmann, J Siveke, M Lahmann, G Singh, ...
The EMBO journal 34 (4), 517-530, 2015
Characterization of the p53 cistrome–DNA binding cooperativity dissects p53's tumor suppressor functions
K Schlereth, C Heyl, AM Krampitz, M Mernberger, F Finkernagel, ...
PLoS genetics 9 (8), e1003726, 2013
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
S Reinartz, F Finkernagel, T Adhikary, V Rohnalter, T Schumann, ...
Genome biology 17 (1), 1-22, 2016
KINK-1, a novel small-molecule inhibitor of IKKβ, and the susceptibility of melanoma cells to antitumoral treatment
M Schön, BG Wienrich, S Kneitz, H Sennefelder, K Amschler, V Vöhringer, ...
Journal of the National Cancer Institute 100 (12), 862-875, 2008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20